Vasotec

Type: Product
Name: Vasotec
First reported 13 hours ago - Updated 12 hours ago - 1 reports

Merck's Mantra On Focus Precludes An Inversion Strategy

Merck recently scored a major triumph for itself and melanoma patients with the approval of an important new drug, Keytruda (pembrolizumab). Keytruda is an entry in the exciting new area of anti-cancer drugs known as immunomodulators, drugs that help ... [Published Forbes.com - 13 hours ago]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

Alarming Side Effects of 7 Popular Prescription Drugs

Legal prescription drugs … Many people take them, many don’t read the endless side effects warnings that seem to go on forever in “mouse type” on the labels and accompanying info sheets. Perhaps they should, and then ask their doctor if the benefits outweigh ... [Published Care2 - Sep 10 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

Check Up: Is Novartis' LCZ696 "revolutionary" or just a marginal improvement?

Daniel R. Hoffman, Ph.D., President, Pharmaceutical Business Research Associates Posted: Wednesday, September 10, 2014, 1:02 PM Filed Under: Daniel HoffmanOver the Labor Day weekend, Novartis presented the results of a trial for its cardiovascular ... [Published Philly.com - Sep 10 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 1 reports

Blockbusters Differentiate Novartis

Novartis reported excellent Phase III data for its heart failure drug LCZ696, leading us to increase our ADR fair value estimate to $91 per share (CHF 83 for the local share) from $83 (CHF 73). In the 8,000-plus patient study, the drug reduced mortality ... [Published Morningstar.com - Sep 05 2014]
Entities: Novartis AG, Drugs, Patent
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

Trial drug improves heart failure patients’ chance of survival

A new drug candidate outperforms a standard treatment in heart failure patients, researchers report August 30 in the New England Journal of Medicine . Those receiving the experimental drug called LCZ696 were less likely to die during the study than those ... [Published Science News Online - Sep 03 2014]
First reported Sep 02 2014 - Updated Sep 03 2014 - 1 reports

Experimental Drug Helps Heart-Failure Patients

In a WebMD article, an experimental drug was said to be more effective than standard treatment at preventing deaths and hospitalizations in heart-failurepatients. According to the study authors, the trial was stopped early because of the marked benefit ... [Published Pharmaceutical Manufacturing Magazine - Sep 02 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

Novartis Srock Reaches 3-Year High On Successful Heart Failure Drug Trials

Novartis AG traded up 4.3% yesterday. Successful Phase III trials of the company’s experimental heart failure drug, LCZ696 led to the highest single-day gain in stock over the past three yearsPage 1 of 2Click Ticker to See live coverageNovartis AG ADR ... [Published Bidness Etc - Sep 02 2014]
First reported Sep 01 2014 - Updated Sep 02 2014 - 1 reports

Drug Gives 'New Hope' Against Heart Failure, Expert Says

By Steven ReinbergSATURDAY, Aug. 30, 2014 (HealthDay News) -- In a head-to-head comparison, an experimental drug was more effective than standard treatment at preventing deaths and hospitalizations in heart failure patients.According to the study authors, ... [Published Bio-Medicine - Sep 01 2014]
First reported Aug 30 2014 - Updated Aug 31 2014 - 2 reports

Study: New Novartis Heart Failure Drug Shows Big Promise

By Marilynn Marchione A new study reports one of the biggest potential advances against heart failure in more than a decade -- a first-of-a-kind, experimental drug that lowered the chances of death or hospitalization by about 20 percent. Doctors say ... [Published The Street Latest - Aug 31 2014]
First reported Aug 07 2014 - Updated Aug 07 2014 - 1 reports

spironolactone, Aldactone

Pharmacy Author:Omudhome Ogbru, PharmDDr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. ... [Published MedicineNet.com - Aug 07 2014]
First reported May 02 2014 - Updated May 02 2014 - 1 reports

VASOTEC (Enalapril Maleate) Tablet VASOTEC (Enalapril Maleate) Tablet [BTA Pharmaceuticals Inc.]

Quotes

"We found that LCZ696 was superior to the gold-standard ACE inhibitor for heart failure -- an ACE inhibitor being the absolute cornerstone of treatment for this problem" he said
"It's been at least a decade since we've had a breakthrough of this magnitude" said Yancy, who had no role in the study
The drug, called LCZ696, is expected to "fundamentally change the current treatment of chronic heart failure patients" according to MUSC's Dr. Michael Zile, an international investigator for a study titled, "Paradigm-HF."

More Content

All (13) | News (12) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Merck's Mantra On Focus Precludes An Inversion ... [Published Forbes.com - 13 hours ago]
Alarming Side Effects of 7 Popular Prescription... [Published Care2 - Sep 10 2014]
Check Up: Is Novartis' LCZ696 "revolutionary" o... [Published Philly.com - Sep 10 2014]
Blockbusters Differentiate Novartis [Published Morningstar.com - Sep 05 2014]
Trial drug improves heart failure patients’ cha... [Published Science News Online - Sep 03 2014]
Novartis may have game-changing drug [Published Medical Marketing And Media - Sep 03 2014]
Experimental Drug Helps Heart-Failure Patients [Published Pharmaceutical Manufacturing Magazine - Sep 02 2014]
Novartis Srock Reaches 3-Year High On Successfu... [Published Bidness Etc - Sep 02 2014]
Drug Gives 'New Hope' Against Heart Failure, Ex... [Published Bio-Medicine - Sep 01 2014]
Study: New Novartis Heart Failure Drug Shows Bi... [Published The Street Latest - Aug 31 2014]
MUSC researchers part of breakthrough drug for ... [Published Charleston Post and Courier - Aug 30 2014]
spironolactone, Aldactone [Published MedicineNet.com - Aug 07 2014]
VASOTEC (Enalapril Maleate) Tablet VASOTEC (Ena... [Published DailyMed Drug Label Updates for the last seven ... - May 02 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
VASOTEC (Enalapril Maleate) Tablet VASOTEC (Ena... [Published DailyMed Drug Label Updates for the last seven ... - May 02 2014]
Updated Date: May 2, 2014 EST ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.